万孚生物
(300482)
| 流通市值:67.05亿 | | | 总市值:73.13亿 |
| 流通股本:4.29亿 | | | 总股本:4.68亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,568,892,198.99 | 1,038,506,474.79 | 581,742,751.09 | 2,086,830,072.65 |
| 营业总成本 | 1,453,233,686.87 | 924,188,328.32 | 491,970,446.34 | 2,249,566,528.36 |
| 其他经营收益 | | | | |
| 营业利润 | 159,071,016.38 | 142,567,604.25 | 97,917,656.29 | -110,415,843.1 |
| 利润总额 | 150,429,143.55 | 140,553,784.88 | 97,178,541.97 | -114,693,306.93 |
| 净利润 | 138,165,819.67 | 125,155,264.06 | 86,122,468.23 | -69,658,473.46 |
| 每股收益 | | | | |
| 其他综合收益 | -17,212,215.4 | 7,017,702.46 | 18,116,871.33 | 42,498,484.27 |
| 综合收益总额 | 120,953,604.27 | 132,172,966.52 | 104,239,339.56 | -27,159,989.19 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 3,566,588,480.45 | 3,775,264,539.97 | 3,456,884,307.57 | 3,301,305,228.24 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,471,497,268.08 | 2,965,382,068.98 | 3,277,283,824.7 | 3,300,371,989.71 |
| 资产总计 | 6,038,085,748.53 | 6,740,646,608.95 | 6,734,168,132.27 | 6,601,677,217.95 |
| 流动负债: | | | | |
| 流动负债合计 | 485,700,636.9 | 1,138,710,676.62 | 1,072,683,956.68 | 1,038,875,368.86 |
| 非流动负债: | | | | |
| 非流动负债合计 | 85,574,358.22 | 93,612,631.06 | 83,664,022.85 | 89,242,035.91 |
| 负债合计 | 571,274,995.12 | 1,232,323,307.68 | 1,156,347,979.53 | 1,128,117,404.77 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,403,590,807.51 | 5,446,757,020.89 | 5,517,163,417.51 | 5,414,625,996.42 |
| 股东权益合计 | 5,466,810,753.41 | 5,508,323,301.27 | 5,577,820,152.74 | 5,473,559,813.18 |
| 负债和股东权益合计 | 6,038,085,748.53 | 6,740,646,608.95 | 6,734,168,132.27 | 6,601,677,217.95 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,769,653,555.16 | 1,245,535,778.19 | 602,273,018.23 | 2,511,134,882.94 |
| 经营活动现金流出小计 | 1,265,351,905.94 | 821,537,415.07 | 384,103,290.17 | 2,048,097,322.09 |
| 经营活动产生的现金流量净额 | 504,301,649.22 | 423,998,363.12 | 218,169,728.06 | 463,037,560.85 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 4,623,358,510.17 | 2,827,353,191.68 | 1,607,461,222.84 | 4,661,584,129.73 |
| 投资活动现金流出小计 | 4,536,272,344.61 | 3,306,393,453.28 | 1,916,196,520.18 | 5,079,044,103 |
| 投资活动产生的现金流量净额 | 87,086,165.56 | -479,040,261.6 | -308,735,297.34 | -417,459,973.27 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,969,515.73 | 1,374,277.71 | 653,096.58 | 7,046,953.46 |
| 筹资活动现金流出小计 | 788,567,244.18 | 102,664,544.18 | 0 | 417,389,617.13 |
| 筹资活动产生的现金流量净额 | -786,597,728.45 | -101,290,266.47 | 653,096.58 | -410,342,663.67 |
| 汇率变动对现金及现金等价物的影响 | -4,449,395.52 | -3,606,874.27 | -1,385,935.36 | -1,339,102.5 |
| 现金及现金等价物净增加额 | -199,659,309.19 | -159,939,039.22 | -91,298,408.06 | -366,104,178.59 |
| 期末现金及现金等价物余额 | 262,339,540.87 | 302,059,810.84 | 370,700,442 | 461,998,850.06 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -159,939,039.22 | - | -366,104,178.59 |
最新报告期:2026-10-28| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华泰证券 | 代雯,高鹏 | 0.44 | 0.72 | 0.85 | 2026-10-28 |
| 中信建投 | 李虹达,王在存,贺菊颖 | 0.62 | 0.69 | 0.76 | 2026-10-01 |
| 华创证券 | 郑辰,李婵娟 | 0.65 | 0.76 | 0.90 | 2026-09-30 |
| 华泰证券 | 代雯,高鹏 | 0.57 | 0.66 | 0.78 | 2026-08-23 |